펨테크 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 및 부문 예측(2026-2033년)

FemTech Market Summary

The global femtech market size was valued at USD 45.6 billion in 2025 and is projected to grow from USD 52.9 billion in 2026 to USD 145.5 billion in 2033, at a CAGR of 15.5% from 2026 to 2033. North America dominated the market, accounting for the largest share of 45.7% in 2025. The growth of the femtech industry is driven by rising awareness of women's health, the adoption of digital healthcare solutions, and the growing demand for technologies for fertility, pregnancy, menstrual, and menopause management.

In addition, the rising prevalence of infertility, PCOS, endometriosis, menopause-related conditions, and other reproductive health disorders is increasing the demand for femtech solutions. The growing adoption of mobile health applications, wearable devices, virtual care platforms, and AI-enabled diagnostic tools is improving access to personalized women's healthcare. Companies such as Flo Health, Maven Clinic, Clue, Natural Cycles, Elvie, and Willow are strengthening their digital health offerings across fertility, menstrual health, pregnancy, menopause, and preventive care, thereby supporting the market expansion.

Rising investment in women's health startups is also supporting market growth by enabling companies to expand their product portfolios, strengthen technology capabilities, and improve access to digital care solutions. For instance, Maven Clinic raised USD 125 million in Series F funding in October 2024, increasing its valuation to USD 1.7 billion. The funding is expected to support the expansion of AI-enabled women's healthcare services, fertility benefits, menopause care, and global digital health solutions. In 2025, Maven further partnered with OURA to integrate wearable biometric data into personalized women's healthcare, highlighting the growing role of connected health technologies in femtech.

Global FemTech Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global femtech market report based on type, application, end-use, and region:

• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Devices
• Software
• Services
• Consumer Products
• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Pregnancy and Nursing Care
• Reproductive Health & Contraception
• Menstrual Health
• General Health
• Pelvic & Uterine Health
• Sexual Health
• Women's Wellness
• Menopause Care
• Longevity & Mental Health
• End-use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Direct to Consumer
• Hospitals
• Surgical Centers
• Fertility Clinics
• Diagnostic Centers
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
  • Iceland
  • Finland
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Singapore
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Israel

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Volume Price Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rise in adoption of digital health solutions
    • 3.2.1.2. Advancement in artificial intelligence and virtual assistance
    • 3.2.1.3. Growth in investments and funding in the femtech industry
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness about femtech products and applications in developing nations
    • 3.2.2.2. Cybersecurity and privacy concerns
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
• 3.4. Case Study
• 3.5. Integration of AI in the FemTech Industry

Chapter 4. Type Business Analysis

• 4.1. Type Market Share, 2025 & 2033
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million/Billion)
• 4.4. Devices
  • 4.4.1. Devices market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 4.5. Software
  • 4.5.1. Software market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 4.7. Digital Platforms
  • 4.7.1. Digital Platforms market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 4.8. Consumer Products
  • 4.8.1. Consumer products market estimates and forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 5. Application Business Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, by Application, 2021 to 2033 (USD Million/Billion)
• 5.4. Pregnancy and Nursing Care
  • 5.4.1. Pregnancy and nursing care market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.5. Reproductive Health & Contraception
  • 5.5.1. Reproductive health & contraception market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.6. Menstrual Health
  • 5.6.1. Menstrual health market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.7. General Health
  • 5.7.1. General health market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.8. Pelvic & Uterine Health
  • 5.8.1. Pelvic & uterine health market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.9. Sexual Health
  • 5.9.1. Sexual health market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.10. Women's Wellness
  • 5.10.1. Women's wellness market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.11. Menopause Care
  • 5.11.1. Menopause care market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 5.12. Longevity & Mental Health
  • 5.12.1. Longevity & mental health market estimates and forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 6. End Use Business Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, by End Use, 2021 to 2033 (USD Million/Billion)
• 6.4. Direct To Consumer
  • 6.4.1. Direct to consumer market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 6.6. Surgical Centers
  • 6.6.1. Surgical centers market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 6.7. Fertility Clinics
  • 6.7.1. Fertility Clinics market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 6.8. Diagnostic Centers
  • 6.8.1. Diagnostic Centers market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Regional Estimates & Trend Analysis by Type, Application & End Use

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. North America femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. U.S. femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Canada femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. Mexico femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 7.5. Europe
  • 7.5.1. Europe femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Germany femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.3. UK
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. UK femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. France femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. Italy femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Spain femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Denmark femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Sweden femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Norway femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.10. Russia
    • 7.5.10.1. Key country dynamic
    • 7.5.10.2. Regulatory framework
    • 7.5.10.3. Competitive insights
    • 7.5.10.4. Norway femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.11. Iceland
    • 7.5.11.1. Key country dynamic
    • 7.5.11.2. Regulatory framework
    • 7.5.11.3. Competitive insights
    • 7.5.11.4. Norway femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.5.12. Finland
    • 7.5.12.1. Key country dynamic
    • 7.5.12.2. Regulatory framework
    • 7.5.12.3. Competitive insights
    • 7.5.12.4. Norway femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Japan femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. China femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. India femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. South Korea femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Australia femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. Thailand femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.6.8. Singapore
    • 7.6.8.1. Key country dynamic
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive insights
    • 7.6.8.4. Thailand femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 7.7. Latin America
  • 7.7.1. Latin America femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. Brazil femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Argentina femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
• 7.8. MEA
  • 7.8.1. MEA femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamic
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive insights
    • 7.8.2.4. South Africa femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamic
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive insights
    • 7.8.3.4. Saudi Arabia femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamic
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive insights
    • 7.8.4.4. UAE femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamic
    • 7.8.5.2. Regulatory framework
    • 7.8.5.3. Competitive insights
    • 7.8.5.4. Kuwait femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 7.8.6. Israel
    • 7.8.6.1. Key country dynamic
    • 7.8.6.2. Regulatory framework
    • 7.8.6.3. Competitive insights
    • 7.8.6.4. Kuwait femtech market estimates and forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Chiaro Technology Limited
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product and Service benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. HeraMED
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product and Service benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Flo Health, Inc.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product and Service benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Natural Cycles USA Corp
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product and Service benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Glow, Inc
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product and Service benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Allara Health
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product and Service benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. NUVO Inc.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product and Service benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Bloomlife
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product and Service benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Syrona Health
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product and Service benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Sirona Hygiene Private Limited
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product and Service benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Samplytics Technologies Private Limited
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product and Service benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. iSono Health, Inc.
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product and Service benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Athena Feminine Technologies
    • 8.5.13.1. Overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product and Service benchmarking
    • 8.5.13.4. Strategic initiatives